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Direct injection of plasmid DNA into the skeletal muscle has been proposed as a means ofeffeeting somatic gone therapy. We examined the influence 
of age and sex on the level orexpression of an SV40-CAT construct injected into mouse muscle. Age markedly affected expression, with peak values 
in the 4--6 week age ¢la~s which were significantly higher than in animals older than 10 weeks. Sex also altered ¢xpn.~ssion, with higher leveh of 
CAT activity seen in males compared to females. We conclude that the rate of growth is important in determining leveh of expression of directly 
injected DNA. 
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1. INTRODUCTION 
Since the original report by Wolff et al. [1] de- 
monstrating the expression of reporter genes following 
the direct injection of plasmid DNA into rodent muscle, 
a number of papers have documented the same phe- 
nomenon in both skeletal [2,3] and cardiac [4-6] muscle 
of rodents, skeletal muscle ofother mammals [7] and the 
skeletal muscle of fish [8]. 
The direct transfer technique has been proposed as a 
means of effecting somatic gene therapy with little dan- 
ger of  genetic side effects as the DNA appears to persist 
as an extrachromosomal circular plasmid [1]. Addition- 
ally, no immune reactions or adverse side effects were 
noted in a recent study in non-human primates, even 
after repeated treatments [7]. A further advantage is 
that the injected plasmids continue to show expression 
for at least one year [9]. Unfortunately, application is 
hampered by variable results and the transfection of  
only a limited number of myofibers [2]. The current 
report examines two possible causes of variation, 
namely the age and sex of the treated animal. This 
complements a recent paper examining some of the 
other factors influencing the expression of injected plas- 
mids [3]. 
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2. MATERIALS AND METHODS 
2.1. PlasmM production 
The experiments utilised the SV40 early promotor coupled to the 
chloramphenicol acctyltranfferase r porter gone (pCAT-Control, 
Promega). Plasmid DNA was prepared using Quiagen columns (Di- 
agen) following the supplier's protocol and was checked for concentra- 
tion and quality by UV spectrophotometry and no, arose gel electro- 
phoresis [10]. 
2.2. lt#ction of plasmid DNA in vh,o 
C57B1/10 ScSn mice were reared under aconventional management 
system with food and water availabl~ ad libitum. 100/~g of plasmid 
DNA in 20% sucrose, final volume 100/~1, was injected through a 27 
gauge needle into the middle of the quadricep~ muscle of mice anaes- 
thetised with Avertin or a mixture of Hypnorm and Hypnovel [11]. No 
skin incision was made and care was taken to identify and avoid the 
fat pad overlying the antero-proximal portion of the quadriceps mus- 
cle, particularly inolder mice. Animals of a range ofages were injected 
with each plasmid preparation. 
2.3. Chloramphenicot acetyltrans~,rase says 
72 h later the mice were sacrificed by cervical dislocation and the 
entire quadrieeps excised. The muscle was frozen in liquid nitrogen 
and ground to a fine powder using a pro-cooled mortar and pestle. The 
sample was then transferred to a i.5 ml tube and r~uspendcd in 200 
/.tl of 0.25 M Tris-HCl, pH 7.8. The sample was subjected to three 
cycles of freezing and thawing (37"C), centrifuged using a Hcracu5 
mic,'ofage at 13,000 rpm for 5 rain, and the supenmtant i cubated at 
65°C to inactivate endogenous aeetyltransferases. After centrifagation 
at 13,000 rpm for 2 rain, the supernatant was mixed with 100/al of 1 
M Tris-HCl, pH 7.8, 20 ~1 of acetyl e, oenzyme A (4 rental) and 2 Itl 
t~C-labelled chloramphcnicoi (57.9 mCi/mmol, 0.05 mCi/ml). The 
mixture was incubated at 37°2 for 4 h and the product resolved by 
thin layer chromatography ll0]. X-my fi!m was exposed overnight to 
the TLC plates. CAT activity was measured as the percentage of 
chloramphenicol conversion to aeetylated forms using a laser den- 
sitometer (Chromosean 3, Joyee-Loebl). 
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Fig. 2. CAT actlvit~, measured as the per:.entage of ehloramphenicol 
conversion to aeetylated forms, of samples taken 72 h after injection 
of 100 ~'g of pSVCAT into the quadriceps of male and female mice 
of various ages. T-Bars represent the standard error. One way 
ANOVA, P<0,05, for age. Expression is signifieantl>' lower ila the 
10~22-week-old groups compared to the 4-6-week-old group (paired 
t.tests, *P<0,05, **P<0.OI). 
A B C D E 
Fig, 1. A typical CAT assay with sample~ taken 72 11 after injection 
of mouse quadrieeps muscle with 100/.tg ofpSWCAT, Lane A, 8-week- 
old male, 79% CAT activity; lane B, l l-week-old male, 25.5% CAT 
activity; lane C, 13-week.old male, 16.3% CAT activity; hme D, 15- 
week-old male, 4% CAT activity; lane E, 20-week.old male. 0.3% CAT 
activity. 
3. RESULTS 
3.1. Influence of age 
The animals showed no signs of  locomotor impair- 
ment or other adverse reactions following treatment. 
Considerable individual variation in expression of  the 
injected DNA was obse~.,ed within each age group. De- 
spite this variation, animal age had a marked effect on 
the degree of  plasmid expression (Fig. 1). Younger ani- 
mals demonstrated higher levels of  CAT activity than 
older animals (Fig. 2, ANOVA P<0.05). The highest 
levels of expression were obtained in the 4-6 week age 
group, significantly higher than in animals older than 
10 weeks. Very young animals (<2 weeks old) do not 
show good expression and appeal" to thrive poorly fol- 
lowing treatment, either due to muscle damage or the 
effects of  anaesthesia. Therefore only one very young 
animal was included in this study. 
3.2. h~uenee of sex 
The sex of  the treated animal appears to influence the 
degree of  expression of  the injected plasmid DNAo with 
males exhibiting greater expression than females, al- 
though the difference is only statistically significant at 
2-4 and 10-12 weeks, The effect o f  age is clearly ob- 
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served in males but age does not appear to have such 
a significant effect in females, due to low levels of  ex- 
pression and considerable variation (Fig, 3A, males 
ANOVA P<0.05; Fig. 3B, females ANOVA not signifi- 
cant). However, the trend appears to be the same be- 
tween the two sexes. 
4, DISCUSSION 
The major finding of these studies is the observation 
that age significantly influences the level of  expression 
of  the injected plasmid. Higher yields of the reporter 
Table I
S;udy Species (strain) Age Sex 
Wolff et al, [1] Mouse (Bulb/c) 5-6 weeks Mixed 
Lin et al, [5] Rat (SD) 6-11 weeks ? 
(250 g) 
Acsadi ct al, [2] Mouse (rndx) 4-6 weeks '> 
Acsadi et al. [4] Mouse (Balb/c) 9 ? 
Mouse (Balb/¢) 4 weeks ? 
Rat (SDj Adult ? 
Rat (nude SD) '? ? 
Rat (SD) 150-280 g ? 
Han.~n et al. [~] Carp Young (10 era) ? 
Carp Old (20 cm) o 
Kitsis et al. [6] Rat (Wistar) Adult Female 
Wolff ¢t al, [31 Mouse (Balb/c) 6 weeks Mixed 
Rat 5-7 w~eks " 
Rat 1 day ? 
.line et al. [71 Rhesus monkey 5-11 :years ? 
Cat ? ? 
Rat ? ? 
SD = Spraguo-Dawley 
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Fig, 3. (A) CAT activity measured asthe percentage ofchlorampheni- 
col conversion to acetylated forms, of samples from treated male mice 
of various ages. T-Bars represent the standard error. One way 
ANOVA, P<0,05, lbr age, Expression is significantly ower in the 
10-16 and 18-22-week-old groups compared to the 4--6-week-old 
group (paired t-tests. *P<0.05, **P<0.01), (B) CAT activity of sam- 
ples from treated female mice of various ages. T-Bars represent the 
standard error. One way ANOVA, not significant. 
protein were obtained when young animals (ranging 
from 2-10 weeks old) were treated, particularly those 
4-6 weeks old. Perhaps fortuitously, this is also the age 
range used in most of  the previously reported mouse 
studies (e.g. [1-4]). Regrettably, a number of  studies 
have failed to record the age and sex of the treated 
animals (see Table 1). Certainly, future studies should 
carefully consider these variables. For  example, the 
comparative study conducted by Jiao and colleagues [7] 
used adult primates in comparison with young mice 
(from [3]) and the conclusions hould be regarded with 
caution. 
An explanation of differences due to age and sex may 
lie in the growth rate of the treated animals. Mice show 
rapid growth from three to approximately 10 weeks of  
age followed by a marked reduction in rate for the 
following weeks of life (e.g. [12]). This might affect plas- 
mid expression either by increased uptake of  the plas- 
mid or by increased transcription/translation pergene 
copy. Females grow less rapidly than males and this 
could explain the decreased expression of injected DNA 
in females compared to males. Variation in individual 
growth rates and response to the stress of  treatment 
might well account for some of  the marked individual- 
to-individual variation recorded in these and other ex- 
periments. Age effects are not confined to mice; in- 
creased CAT expression has been recorded in young 
compared to older fish [8]. 
In conclusion, this report extends the number o f  var- 
iables known to affect the direct injection technique. 
Future studies hould pay more attention to the age. sex 
and physiological state of  experimental subjects. The 
strain and husbandry conditions should also be re- 
corded as these variables will affect growth rate. Most 
significantly, the results suggest hat direct muscle gen¢ 
therapy would be most successful in younger patients. 
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